CLINICAL OUTCOMES AND MOLECULAR CHARACTERIZATION FROM a PHASE II STUDY OF COPANLISIB IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA

CLINICAL OUTCOMES AND MOLECULAR CHARACTERIZATION FROM a PHASE II STUDY OF COPANLISIB IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA

Saved in:
Bibliographic Details
Published in:Hematological oncology Vol. 35; no. S2; pp. 68 - 69
Main Authors: Lenz, G., Hawkes, E., Verhoef, G., Haioun, C., Lim, S., Heo, D., Ardeshna, K., Chong, G., Christensen, J.H., Shi, V., Lippert, S., Hiemeyer, F., Piraino, P., Beckmann, G., Peña, C., Buvaylo, V., Childs, B.H., Gorbatchevsky, I., Salles, G.
Format: Journal Article
Language:English
Published: Chichester Wiley Subscription Services, Inc 01-06-2017
Subjects:
B-cell lymphoma
Lymphocytes B
Lymphoma
Patients
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0278-0232
1099-1069
DOI:10.1002/hon.2437_56